| Literature DB >> 28696242 |
Tatsuya Tada1,2, Kayo Shimada3, Kazuhito Satou4, Takashi Hirano4,5, Bharat M Pokhrel6, Jeevan B Sherchand6, Teruo Kirikae3,2.
Abstract
A total of 11 multidrug-resistant Pseudomonas aeruginosa clinical isolates were obtained in Nepal. Four of these isolates harbored genes encoding one or more carbapenemases (DIM-1, NDM-1, and/or VIM-2), and five harbored genes encoding a 16S rRNA methyltransferase (RmtB4 or RmtF2). A novel RmtF variant, RmtF2, had a substitution (K65E) compared with the same gene in RmtF. To our knowledge, this is the first report describing carbapenemase- and 16S rRNA methyltransferase-coproducing P. aeruginosa clinical isolates in Nepal.Entities:
Keywords: 16S rRNA methylase; Pseudomonas aeruginosa; carbapenemase; multidrug resistance
Mesh:
Substances:
Year: 2017 PMID: 28696242 PMCID: PMC5571325 DOI: 10.1128/AAC.00694-17
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191